G3 Global Berhad

RM 0.01As of Sun 8 Nov 2026, 12:00 UTC

KLSE:G3Healthcare

Country Malaysia

PE (Fwd) •••

TSR 10Y CAGR (18.69%)

Div yield —

ROE (29.68%)

Medical, Dental, and Hospital Equipment and Supplies

Beta (5Y) 0.28

PE TTM —

TSR TTM (25.00%)

Mkt cap RM 62.26M

ROIC (165.49%)

SE Grade™

Value

Quality

Moat

Consensus

Reference

RM 0.0182

21.15%

(69.63%)

Hold 7|1|10|0|3

TTM

FYE 31 Dec MYR

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

5Y

10Y

Peers

9.889

RevenueRM M

12.90

13.45

13.72

14.33

14.77

15.27

15.95

16.37

17.12

17.76

10.91

3.75%

3.46%

56

8.45

Revenue growth%

8.23

8.04

10.64

8.87

10.81

8.28

10.00

7.30

8.45

6.83

10.85

8.28

8.37

14

15.60

Gross margin%

9.26

9.73

12.05

10.78

9.79

9.91

11.01

13.36

13.67

14.39

26.82

13.36

10.90

60

14.24

Operating margin%

7.16

7.43

10.04

8.91

7.86

8.05

10.36

10.05

11.90

11.48

21.63

10.36

9.48

48

3.96

Net margin%

0.40

0.40

0.40

0.40

1.76

3.79

4.65

2.17

2.63

1.26

21.98

2.63

1.51

72

11.82

P/E ratio (avg)x

28.00

27.88

25.23

28.42

30.24

32.34

34.93

33.79

34.17

31.99

34.66

33.79

31.12

69

21.71

EV/EBITx

50.37

52.65

52.63

57.83

58.64

55.28

58.09

60.07

64.95

71.56

18.15

60.07

57.96

34

28.36

FCF yield (avg)%

15.33

16.67

17.04

14.12

13.46

15.50

14.52

16.57

18.14

20.29

17.41

16.57

16.03

58

26.95

FCF margin%

26.75

23.78

21.48

24.47

24.33

22.98

21.66

23.16

24.10

21.47

17.97

22.98

23.47

24

0.808

FCF / Net incomex

0.218

0.225

0.227

0.221

0.257

0.284

0.270

0.253

0.274

0.269

1.730

0.270

0.255

46

24.71

ROIC%

27.77

25.30

26.69

25.05

27.15

27.90

30.83

28.98

29.66

32.41

6.91

29.66

27.84

47

20.69

Return on equity%

20.69

20.50

18.74

18.70

21.59

19.14

21.29

22.50

20.05

19.02

28.19

20.05

20.27

34

18.31

Return on assets%

10.34

13.27

12.64

12.61

11.53

14.49

13.65

11.22

10.85

13.25

19.65

13.25

12.63

76

—

EPSRM

—

—

—

—

—

—

—

—

—

—

—

(2.07%)

(1.38%)

—

19.14

EPS growth%

14.41

16.81

16.39

13.80

15.39

13.10

14.97

16.41

15.75

13.35

19.20

14.97

15.18

93

—

Bookvalue per shRM

—

—

—

—

—

—

—

—

—

—

—

2.11%

3.08%

—

—

FCF per shareRM

—

—

—

—

—

—

—

—

—

—

—

7.31%

6.81%

—

—

Dividend per shRM

—

—

—

—

—

—

—

—

—

—

—

0.17%

2.08%

—

15.62

Div yield (avg)%

0.40

0.40

1.58

1.40

0.40

2.29

0.40

2.55

1.09

0.44

7.57

1.09

0.76

24

29.14

Payout ratio%

20.34

21.56

24.23

24.47

23.05

24.51

26.06

25.89

25.42

28.08

18.77

25.89

24.49

66

4.086

Shares (diluted)B

5.982

6.681

7.580

7.200

7.749

7.240

7.351

7.766

8.806

9.982

4.057

5.19%

6.08%

6

19.28

Buyback yield%

31.62

29.25

26.82

27.18

24.76

21.81

24.40

25.52

26.77

23.87

25.63

24.40

26.15

70

1.590

D/E ratiox

1.887

1.937

1.959

1.908

1.811

2.040

2.208

2.368

2.548

2.456

1.555

2.368

2.000

22

10.10

Enterprise valueRM M

7.154

7.839

8.748

7.982

7.692

8.055

7.260

7.644

8.525

9.333

0.866

3.94%

1.97%

86

9.288

LT debtRM M

8.655

9.551

9.992

10.95

10.81

12.67

14.05

16.10

17.46

19.16

6.953

12.13%

10.05%

66

Peers (US$15.35M)

Cap (US$)

PE

64.09M

4.166x

UMediC Group Berhad

24.43M

12.86x

Careplus Group Berhad

16.76M

—

Cytosorbents Corporati…

15.13M

—

Capital

TTM

5Y

10Y

Leveragex

0.592

0.023

0.026

EBIT/Intx

0.864

0.159

0.161

Own earn%

16.13

114.95

87.54

Sh yield%

34.90

24.80

27.97

Owners

Insiders/Inst%

11.31

64.40

Short interest%

2.55

SBC / revenue%

1.11

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

24

Op margin range%

7–12

$1 testx

—

Incr. ROIC%

57

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

RM 17.76M

3.46%

1.00×

Cost of revenue

RM 10.57M

3.57%

1.01×

Operating expenses

RM 3.066M

3.17%

0.97×